跳至主要内容
临床试验/TCTR20240323002
TCTR20240323002已完成2 期

The Analgesic Efficacy of Lidocaine/Prilocaine (EMLA) cream during Dry Needling of an Active Myofascial Trigger Point in the Upper Trapezius Muscle: A Double-blind Randomized Controlled Trial

Phramongkutklao Hospital Foundation0 个研究点目标入组 64 人开始时间: 2024年3月23日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
64

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 Years 至 N/A (No limit)(—)
性别
All

入选标准

  • 1. Presented at least 1 active Myofascial trigger point in the upper trapezius, 2. Volunteers completing inform consent for their participation and dry needling procedure

排除标准

  • 1. Contraindication for dry needling included needle phobia, coagulopathy, thrombocytopenia, and psychiatric disorder, 2. History of analgesic or NSAIDs use in 24 hours, 3. Altered mental status or inability to comprehend question, 4. Contraindication for EMLA (lidocaine/prilocaine), 5. Pregnant women or breastfeeder, 6. denuded or broken skin over myofascial trigger point site

研究者

发起方
Phramongkutklao Hospital Foundation

相似试验